Cherry Antacid Tablets Recalled for CGMP Deviations
ULTRAtab Laboratories is recalling Cherry Antacid Tablets (Calcium Carbonate 420 mg) in bulk containers due to Current Good Manufacturing Practice (CGMP) deviations. The FDA classified this as a Class II recall.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall for CGMP deviations. The source text does not report any illnesses, injuries, or confirmed product quality failures—only manufacturing process violations. This qualifies as a moderate-severity precautionary recall.
Plain-English summary
ULTRAtab Laboratories, Inc., located in Highland, New York, is voluntarily recalling Cherry Antacid Tablets (Calcium Carbonate 420 mg) distributed in bulk containers. The recall affects approximately 3,052,313 tablets with product code M304 and bulk lots 18K059, 18L106, 18L117, 18M067, and 18M068 (NDC 62959-304-00).
The recall was initiated because the manufacturer identified Current Good Manufacturing Practice (CGMP) deviations during production. The FDA classified this as a Class II recall on February 9, 2022, and the firm voluntarily initiated the recall on January 26, 2022.
The bulk product was distributed to three distributors, who may have further distributed finished products. Consumers who have purchased these antacid tablets should stop using the product. Healthcare providers and distributors who received this product should contact their suppliers for instructions on return or disposal. The recall was terminated on January 7, 2025.
The recalled product
- Product
- Cherry Antacid Tablet (Calcium Carbonate 420 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-304-00
- Manufacturer
- ULTRAtab Laboratories, Inc.
- Hazard
- Affected units
- 3,052,313
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Product Codes: M304 Bulk Lots: 18K059
- 18L106
- 18L117
- 18M067
- 18M068
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 33 recalled by ULTRAtab Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 33 products in this recall →Related recalls
Same manufacturer · ULTRAtab Laboratories, Inc.
See all →- ModerateDBI Magnums Caffeine Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16
- ModerateHPC Tablet Drug Recalled Due to CGMP Manufacturing Deviations
FDA (Drugs) · 2022-02-16
- ModerateMelatonin ER supplement recalled for manufacturing practice deviations
FDA (Food) · 2022-02-16
- ModerateDietary supplement melatonin recall due to manufacturing deviations
FDA (Food) · 2022-02-16
- Moderate
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls MYXREDLIN Insulin Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Clindamycin Phosphate Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09